Factors Affecting the Completion of Adjuvant Chemotherapy in Early-Stage Breast Cancer

Annals of Surgical Oncology

Volumn 23, Issue 5, 2016, Pages 1537-1542

  Reyes, Sylvia A ^a   King, Tari A ^a   Fei, Kezhen ^b   Franco, Rebeca ^b   Bickell, Nina A ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BODY IMAGE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURGERY; FEMALE; FOLLOW UP; HEALTH STATUS; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; MULTICENTER STUDY; OUTPATIENT; SELF CONCEPT; SOCIAL SUPPORT; TREATMENT DURATION; TRIPLE NEGATIVE BREAST CANCER; ADJUVANT CHEMOTHERAPY; AFRICAN AMERICAN; BREAST NEOPLASMS; CAUCASIAN; CLINICAL TRIAL; CONTROLLED STUDY; HEALTH CARE DELIVERY; HEALTH DISPARITY; MEDICATION COMPLIANCE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HEALTH SERVICES ACCESSIBILITY; HEALTH STATUS DISPARITIES; HUMANS; MEDICATION ADHERENCE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SOCIAL SUPPORT;

EID: 84951914359     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-015-5039-5     Document Type: Article

References (24)

1. American Cancer Society. What Are the Key Statistics About Breast Cancer?http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-key-statistics. Accepted 3 Sept 2015.
2. Early Breast Cancer Trialists’ Collaborative G. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687–717.
3. Early Breast Cancer Trialists’ Collaborative G, Clarke M, Coates AS, et al. Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet. 2008;371:29–40.
4. Early Breast Cancer Trialists’ Collaborative G, Peto R, Davies C, et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet. 2012;379:432–44.
5. Ruddy KJ, Pitcher BN, Archer LE, et al. Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907). Ann Oncol. 2012;23:3075–81.
6. Nurgalieva ZZ, Franzini L, Morgan RO, Vernon SW, Liu CC, Du XL. Impact of timing of adjuvant chemotherapy initiation and completion after surgery on racial disparities in survival among women with breast cancer. Med Oncol. 2013;30:419.
7. Hershman DL, Unger JM, Barlow WE, et al. Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897. J Clin Oncol. 2009;27:2157–62.
8. Hershman D, McBride R, Jacobson JS, et al. Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol.2005;23:6639–46.
9. Lipscomb J, Gillespie TW, Goodman M, et al. Black-white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US. Breast Cancer Res Treat. 2012;133:285–96.
10. Bickell NA, Weidmann J, Fei K, Lin JJ, Leventhal H. Underuse of breast cancer adjuvant treatment: patient knowledge, beliefs, and medical mistrust. J Clin Oncol. 2009;27:5160–7.
11. Wells JS, Strickland OL, Dalton JA, Freeman S. Adherence to intravenous chemotherapy in African American and white women with early-stage breast cancer. Cancer Nurs. 2015;38:89–98.
12. Bickell NA, Geduld AN, Joseph KA, et al. Do community-based patient assistance programs affect the treatment and well-being of patients with breast cancer? J Oncol Pract. 2014;10:48–54.
13. Bickell NA, Aufses AH Jr, Chassin M. Engaging clinicians in a quality improvement strategy for early-stage breast cancer treatment. Qual Manage Health Care. 1998;6:63–8.
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.
15. Strogatz DS, Croft JB, James SA, et al. Social support, stress, and blood pressure in black adults. Epidemiology. 1997;8:482–7.
16. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297–334.
17. University of California Los Angeles. SAS Code to Score the SF-12 Version 2.0 (computer program). University of California Los Angeles, Los Angeles, CA, 2004.
18. Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) program population-based study. Arch Intern Med. 2002;162:1985–93.
19. Griggs JJ, Culakova E, Sorbero ME, et al. Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens. J Clin Oncol. 2007;25:2522–7.
20. Subramanian S, Trogdon J, Ekwueme DU, Gardner JG, Whitmire JT, Rao C. Cost of breast cancer treatment in Medicaid_ implications for state programs providing coverage for low-income women. Med Care. 2011;49:89–95.
21. Oestreicher N, Ramsey SD, McCune JS, Linden HM, Veenstra DL. The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma. Cancer. 2005;104:2054–62.
22. Guidry JJ, Aday LA, Zhang D, Winn RJ. Cost considerations as potential barriers to cancer treatment. Cancer Pract. 1998;6:182–7.
23. Weaver KE, Rowland JH, Bellizzi KM, Aziz NM. Forgoing medical care because of cost: assessing disparities in healthcare access among cancer survivors living in the United States. Cancer. 2010;116:3493–504.
24. Richardson LC, Wang W, Hartzema AG, Wagner S. The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer. Breast J. 2007;13:581–7.